Harrow Health Inc
NASDAQ:HROW
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22.2
51.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Operating Margin
Harrow Health Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Harrow Health Inc
NASDAQ:HROW
|
1.7B USD |
11%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD |
44%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
503.6B USD |
27%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
255.1B CHF |
34%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.4B GBP |
24%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
206.2B CHF |
33%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
244.4B USD |
38%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
42%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
209B USD |
11%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.2B USD |
29%
|
Harrow Health Inc
Glance View
Nestled within the bustling world of pharmaceutical innovation, Harrow Health Inc. emerges as a dynamic player with a distinctive business model tailored to transforming ophthalmic healthcare. With its roots planted firmly in the field of eye care, Harrow Health has mastered the art of compounding pharmaceuticals, focusing on delivering affordability and accessibility. The company operates primarily through its subsidiary, ImprimisRx, a compounding pharmacy that serves a robust network of ophthalmologists and optometrists across the United States. ImprimisRx’s unique approach involves creating custom-formulated medications tailored to specific patient needs, often at prices more competitive than traditional offerings. By prioritizing the compounding of prescription medications in its expansive network of accredited pharmacies, Harrow Health crafts a niche in the high-demand ophthalmology sector. Central to Harrow Health’s business strategy is its ability to capitalize on inefficiencies in the traditional drug market. By emphasizing a direct-to-prescriber model, the company circumvents many of the traditional barriers and costs associated with large pharmaceutical firms. This allows for a reduction in drug prices and improves distribution efficiency. Moreover, Harrow Health’s focus extends beyond compounding; it is actively involved in acquiring and licensing innovative ophthalmic technologies and products, constituting a broader ecosystem within eye care. This multi-pronged approach not only drives revenue through direct sales but also strengthens its position in the healthcare sector by investing in emerging therapies and expanding its reach in the marketplace. Such strategic maneuvers allow Harrow Health to sustain its growth trajectory while continuing to champion patient-centered care.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Harrow Health Inc's most recent financial statements, the company has Operating Margin of 11.2%.